Some amino acids levels: glutamine,glutamate, and homocysteine, in plasma of children with chronic kidney disease
Removal from Category 2 does not guarantee long-term regulatory acceptance, nor does it replace the need for clinical judgment, proper sourcing, and compliance with federal and state guidelines
GHK-Cu provides copper-dependent gene regulation, BPC-157 modulates vascular and growth factor signaling, and TB-500 regulates cytoskeletal dynamics and cell migration
HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
TRIUMPH-5: Obstructive sleep apnea in adults with obesity
WHO SHOULD NOT DO TRT TRT is not appropriate for everyone
